Previous studies using gene-targeted mutant mice revealed several molecules important for the development or function of invariant natural killer T (iNKT) cells. However, these gene knockout mice represent cases that are rare in humans. Thus, it remains unclear how naturally occurring allelic variants of these genes or others regulate the numerical and functional diversity of iNKT cells in both mice and humans. Studies in humans are mostly limited to iNKT cells in peripheral blood (PB). It is not known if the relative distribution of iNKT cells between PB and other lymphoid organs is correlated or under common genetic control. To initially address these questions, we analyzed iNKT cells in the spleen, thymus and PB of 38 inbred mouse strains. Percentages of iNKT cells in these three anatomical sites varied significantly in a strain-dependent manner. The correlation between PB and spleen was moderate, and none was observed between PB and thymus. Similarly, proportions of the CD4-expressing subset of iNKT cells differed significantly among inbred strains. The percentages of CD4-positive iNKT cells displayed a strong correlation between PB and spleen, although it remained poor between PB and thymus. Genome-wide association studies across strains identified only partially overlapping loci associated with variability of iNKT cell frequencies within and between differing anatomical sites.
Introduction
CD1d-restricted invariant natural killer T (iNKT) cells are unique immunoregulatory populations with diverse functions. 1 Distinct from conventional CD4 and CD8 T-cells, iNKT cells are selected by CD1d-expressing CD4 þ CD8 þ double positive thymocytes and thereafter, in mice, develop into CD4 þ , CD4 À CD8 À double negative and the interleukin-17-producing subsets. 2, 3 iNKT cells can promote immune responses against tumors and infectious organisms, but they are also paradoxically capable of suppressing autoimmunity. 4 It has been suggested that the seemingly opposite outcomes of immune regulation are due to the preferential involvement of distinct iNKT cell subsets. Alternatively, they could also result from differential iNKT-mediated activation of immunogenic versus tolerogenic dendritic cells at the time when the immune responses are initiated. 5 Defects in iNKT cells have been linked to several diseases, including autoimmune type 1 diabetes (T1D). 6 In the non-obese diabetic (NOD) mouse model of T1D, disease development partly results from the numerical and functional defects in iNKT cells characterizing this strain. 7 This conclusion is based on the findings that NOD mice were protected from T1D by administration of the iNKT cell super-angonist a-galactosylceramide. [8] [9] [10] [11] In addition, it has been reported that CD1d-deficient NOD mice lacking iNKT cells exhibit accelerated T1D. 11, 12 Moreover, increasing iNKT cell numbers by adoptive transfer prevented T1D development in NOD mice. 13, 14 Genetically, multiple T1D susceptibility (Idd) loci have been associated with an altered iNKT cell compartment and likely contribute to disease development in NOD mice by limiting the generation or function of these immune regulators. [15] [16] [17] [18] [19] In contrast to the mouse studies, the role of iNKT cells in human T1D has been controversial. 6 Early studies indicated that frequencies of iNKT cells were reduced in T1D patients, and functionally, they were altered with an impaired ability to produce Th2 cytokines. 20, 21 However, these observations were later challenged by others, as the numerical and functional differences between iNKT cells in human T1D patients and control subjects were not consistently reported. 22, 23 It has also been reported that although no differences were found in the frequencies of total iNKT cells, the proportions of the CD4 þ subset were significantly reduced in humans with or at high risk for T1D. 24, 25 These results are consistent with the idea that different iNKT cell subpopulations have distinct functions and those expressing CD4 preferentially promote tolerance induction. [26] [27] [28] The inconsistent human study reports could be due to several reasons. The most apparent difference between human and murine studies was the source of cells used for comparison. Cells isolated from lymphoid organs, such as the thymus, spleen and lymph nodes were used to compare the frequency of iNKT cells between NOD mice and other non-autoimmune prone control strains. On the other hand, these lymphoid organs are not readily accessible in humans and all the above mentioned clinical studies analyzed peripheral blood (PB) leukocytes. Importantly, it has been shown that the frequencies of PB iNKT cells did not always correlate with those in the thymi of human infants. 29 Furthermore, it has also been shown that despite being significantly reduced in lymphoid organs, numbers of iNKT cells in PB of NOD mice are comparable to that of the BALB/c and C57BL/6 control strains. 30 To date, the only human study that used cells isolated from pancreatic lymph nodes indicated that iNKT cells from T1D patients have a reduced ability to produce interleukin-4, although direct comparisons between pancreatic lymph nodes and PB in the same individuals were not determined. 31 Therefore, additional human studies that analyze iNKT cells in different lymphoid organs are required to further assess their role in T1D.
In addition to the source of cells used for evaluation, the large variations of PB iNKT cell frequencies in humans (4100 fold) also confound the comparison between different subject groups. [23] [24] [25] 29, 32 Although to what extent environmental factors could alter the frequency of iNKT cells in humans is not known, it appears this phenotype is largely genetically controlled. 23 Although not to the level seen in humans, studies using a limited number of inbred mouse strains also showed a high degree of variation in iNKT cell frequencies in the liver. 33 Taken together, these results suggest that the development of iNKT cells is a complex trait controlled by multiple genetic variants that normally exist in humans and mice. One approach to further determine if iNKT cells modulate the development of T1D or other disorders in humans is to ask if disease susceptibility genes or the pathways in which they participate are also involved in controlling the frequency and/or functional activity of such immunoregulatory populations at various anatomical sites. It is also important to determine if the distribution of iNKT cells in PB and lymphoid organs are under a common genetic control. As a first step to address these questions, we surveyed a large panel of inbred mouse strains for the frequencies of iNKT cells in the spleen, thymus and PB, and used a genome-wide association (GWA) mapping approach to identify novel loci that modulate the development/homeostasis of these immune regulators.
Results
Strain-dependent variations of iNKT cell frequencies in the PB, spleen and thymus Development of iNKT cells is reportedly controlled by a large number of genes. 34, 35 However, most of the studies assessed iNKT cell deficiencies resulting from complete expression loss of targeted genes in mutant mice. Studies using a limited number of inbred mouse strains indicate that naturally existing genetic variants also modulate homeostasis and the functional activity of iNKT cells. 33 To further extend these previous findings, we analyzed iNKT cells in the PB, spleen and thymus of 38 inbred mouse strains, selected on a basis of possessing diverse genetic backgrounds. To normalize the variations in the frequencies of total T-cells, we present the results as a proportion of iNKT cells among total TCR b þ cells in the PB and spleen, and of total TCR b high cells in the thymus. As shown in Figure 1 , the percentages of iNKT cells in different strains were highly variable in the PB and both lymphoid organs (Po0.0001 across all strains, one-way analysis of variance (ANOVA)). iNKT cell percentages ranged from 3.2 to 0.01% in the PB, 4.12 to 0.02% in the spleen, and 9.39 to 0.02% in the thymus, a variation level comparable to what was reported in humans. [23] [24] [25] 29, 32 It is worth noting that all wild-derived inbred strains (CAST/ EiJ, MOLF/EiJ, MSM/Ms, PWD/PhJ, SPRET/EiJ and WSB/EiJ) had low proportions of iNKT cells at each examined site. In particular, iNKT cells were almost not detectable in MSM/Ms and PWD/PhJ mice. NOD mice that were reported to have reduced numbers of iNKT cells were indeed found to be at the low end of the spectrum at each anatomical site, compared with the array of analyzed strains (most not previously examined), further supporting the role of iNKT cells in the regulation of T1D.
Strain-dependent development of iNKT cell subsets
Mouse iNKT cells can be grouped into two subsets on the basis of the surface expression of CD4 molecules. Therefore, we asked if different strains exhibited preferential accumulation of the CD4 þ subsets in the PB, spleen and thymus. Because the overall frequencies of iNKT cells in the PB, spleen and thymus of PWD/PhJ, SPRET/EiJ and MSM/Ms mice, as well as the PB of the CAST/EiJ strain were all extremely low, these strains were excluded from the CD4 þ iNKT cell subset analyses in the corresponding anatomical sites. Similar to the percentages of total iNKT cells, the proportions of the CD4 þ subset also showed profound strain-dependent variations in all three anatomical sites ( Figure 2 , Po0.0001 across all strains, one-way ANOVA). Functional differences have been ascribed to CD4 þ and double negative iNKT cells, as in several disease models, the former subset preferentially exerted immunological tolerance induction activities. [26] [27] [28] 36 When compared with most other strains, NOD mice also had reduced proportions of CD4 þ iNKT cells ( Figure 2 ). These results further support our previous studies, indicating that CD4 þ iNKT cells are part of an immunoregulatory network modulating T1D development. 36 
Correlation of iNKT cells in PB and in lymphoid organs
We next determined if the percentage of iNKT cells in PB can reflect that in the spleen and thymus. We determined the Pearson's correlation between PB and splenic iNKT cells, and between those in PB and the thymus. As presented in Figure 3a , the percentages of total iNKT cells in the PB and spleen showed an overall positive, but only moderate correlation (r ¼ 0.6336, Po0.0001). In contrast, no correlation was found between the percentages of total iNKT cells in the PB and thymus (Figure 3b These analyses clearly showed a strain-dependent variation in the relative distribution of iNKT cells in PB and lymphoid organs (Po0.0001 across all strains, one-way ANOVA). In only a handful of strains does the percentage of iNKT cells in PB reflect those in lymphoid organs. In most cases, the frequency of iNKT cells in PB was found to underestimate that in lymphoid tissues. Interestingly, in three wild-derived strains (SPRET/EiJ, CAST/EiJ, PWD/PhJ) characterized by overall very low levels of iNKT cells (Figure 1 ), the frequency of such immunomodulatory cells in PB would overestimate those in the thymus (Figure 4b ).
Genome-wide association mapping
The GWA mapping approach has had some success in identifying genetic loci that control important biological processes in mice. [37] [38] [39] The large panel of inbred mouse strains analyzed here and the availability of the highdensity single-nucleotide polymorphism (SNP) genotyping data provided us an opportunity to perform GWA mapping of several of the iNKT cell-related traits evaluated in this study. As SNP genotyping results were not available for the SPRET/EiJ strain, it was not included in the mapping study. We chose the percentages of iNKT cells in the spleen and thymus (Figures 1b and c) as phenotypes for association mapping studies to evaluate if genetic regions or genes previously found to regulate the development and homeostasis of these cells 34, 35 could be identified in our studies. We further attempted to identify loci that regulate the PB:spleen iNKT cell ratio (Figure 4a ) as a phenotype for the association mapping studies. SNP data were originally obtained from the Center of Genome Dynamics at The Jackson Laboratory (http://cgd.jax.org/), and analyzed as described in the Materials and methods section. A complete list of SNPs used for GWA mapping will be provided upon request. On the basis of a score of 5 or higher (Po10
À5
), several loci on chromosomes (Chr.) 4, 6, 7, 9, 10, 12, 14, 19 and X were found to be significantly associated with the percentages of thymic iNKT cells (Figure 5a ). Several peaks on Chr. 4, 5, 6, 7, 10, 12, 17 and 19 were found to be linked to the frequencies of splenic iNKT cells (Figure 5b ). Multiple loci on Chr. 1, 2, 4, 5, 6, 8, 9, 10, 11, 13, 14, 17 and X were identified to regulate the PB:spleen ratio (Figure 5c ). The location of the loci found by GWA analyses to regulate various aspects of iNKT cell development and the complete list of genes within them are summarized in Tables 1-3 . Interestingly, as indicated in Tables 1 and 2 , regions on Chr. 4, 6, 7, 10, 12 and 19 were indicated to contain a gene(s) commonly contributing to both thymic and splenic iNKT cell levels. Among these, a cluster of genetic loci on the proximal end of Chr 7 was found to jointly contribute to both thymic and splenic iNKT cell levels. However, unexpectedly no genes previously reported to regulate iNKT cell development mapped to any of these chromosomal regions.
34,35
Discussion A survey approach utilizing 38 classical and wildderived inbred mouse strains was used to further understand the genetic control of iNKT cell development. Our primary finding is that the degree of variation in iNKT cell frequency across multiple inbred mouse strains is similar to what has been observed in humans. [23] [24] [25] 29, 32 As our mice were housed in a well-controlled specific pathogen-free environment, the genetic background is expected to be the primary contributor to the observed strain-dependent variation. Previous studies in identical twins also suggested that the genetic background contributes more significantly than environmental factors to the variation of iNKT cell frequencies in humans. 23 Taken together, these results indicate that development of iNKT cells in both humans and mice is a complex trait that requires further studies to more fully understand its genetic basis. An important finding of the current study stems from the comparison of iNKT cell levels in PB and lymphoid organs. These analyses revealed that although there is some correlation, levels of total iNKT cells in PB do not necessarily predict their frequency in lymphoid tissue. We also confirm that compared with most of the strains analyzed, autoimmune T1D-prone NOD mice have severely reduced levels of iNKT cells. However, NOD mice exhibited a higher PB:spleen ratio of total iNKT cells compared with many other strains (Figure 4 ). This observation was in line with a previous report. 30 Although weak for total iNKT cells, there is a strong correlation between PB and spleen in the proportion of the CD4 þ subset. Taken together, these results suggest that in PB-based human studies, analyses of the proportion of CD4 þ rather than total iNKT cells may provide a more consistent and reliable readout of their levels in lymphoid tissues. A somewhat surprising finding in our current studies is that most wild-derived inbred mouse strains had very low frequencies of iNKT cells (Figure 1 ). Some of them had barely detectable iNKT cells. Polymorphisms in the CD1d1 gene found in wild-derived inbred strains of Mus spretus and Mus musculus castaneus origins affect its antigen presentation function. 40 When congenically expressed in C57BL/6 mice, Mus spretus-derived CD1d1 molecules had a diminished ability to select iNKT cells resulting an B50% reduction of these cells in the thymus. 40 Therefore, the allele difference in CD1d1 could contribute to the overall low frequencies of iNKT cells in the wild-derived inbred strains examined here. However, the extremely low levels of iNKT cells in some of those strains, such as SPRET/EiJ (Mus spretus), cannot be explained solely by the previously reported polymorphisms in the CD1d1 gene. Furthermore, the MSM/Ms strain that belongs to the Mus musculus molossinus subspecies, previously found to have the same CD1d1 allele as that in C57BL/6 mice, virtually lacked iNKT cells (Figure 1 ). GWA studies did not reveal an association of any analyzed iNKT phenotype with a genetic control component on Chr. 3 where the CD1d1 gene is located. Although this could be explained by the exclusion of SPRET/EiJ from the mapping studies, it also suggests that the overall contribution of the CD1d1 polymorphisms from other wild-derived inbred strains, such as CAST/EiJ, is relatively weak to reach the threshold for the whole-genome association study. Collectively, these results indicate that genetic components other than CD1d1 polymorphisms contribute more strongly to the largely reduced iNKT cell levels in wild-derived inbred strains. Therefore, identification of the other genetic components that inhibit the development of iNKT cells in the wild-derived inbred strains represents an area warranting further studies.
GWA mapping studies identified loci on on Chr. 4, 6, 7, 10, 12 and 19 were found to contain a gene(s) regulating the levels of both thymic and splenic iNKT cells. In this regard, the proximal end of Chr. 7 is of particular Abbreviations: iNKT, invariant natural killer; NA, not available. Chromosomal regions noted in bold and underlined contain a gene(s) commonly contributing to both thymic and splenic iNKT cell levels.
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interest, as it contains a cluster of loci linked to levels of both thymic and splenic iNKT cells. This Chr. 7 cluster includes a region between 3.10-3.62 Mb, where several microRNAs (Mir290 to Mir295) are located. This may be of significance as microRNAs are reported to be important for normal iNKT cell development. 41, 42 In addition, the most significant region detected in our entire analyses (peak score ¼ 17.24) was for a locus on Chr. 12 regulating levels of thymic iNKT cells. Genes within these collective regions will be prioritized for future studies. Previous studies using a backcross approach from C57BL/6 to NOD.Nkrp1 b mice identified two loci, respectively, on Chr. 1 and 2, significantly linked to the frequency of thymic iNKT cells. 43 Both the loci (Nkt1 and Nkt2) were subsequently confirmed by congenic analysis, and Slamf1 and Slamf6 within the Nkt1 locus have also been shown to regulate iNKT cell development. 17, [44] [45] [46] To our surprise, neither locus was detected by our GWA mapping across strains for thymic iNKT cell frequencies. One possible explanation is that the statistical power in our study was not high enough to detect Nkt1 and Nkt2 due to the increased genetic complexity and an insufficient number of inbred strains used in our study. In a genetically more complex, but overall small population as in our case, contributions from other loci may exceed Nkt1 and Nkt2 in terms of ability to regulate thymic iNKT cells. A non-mutually exclusive possibility is that other genetic variants present in some of the strains analyzed here mask the effect of Nkt1 and Nkt2. As a result, the likelihood to detect these two loci in our analysis is reduced. In any case, it can be predicted that more loci than Nkt1 and Nkt2 can be identified if different pairs of inbred mouse strains were chosen for an F2 or first-backcross analyses to map genes controlling the development of iNKT cells. Our results also further indicate the development and anatomical distribution of iNKT cells are complex traits that remain to be fully dissected. Although GWA studies have provided a tremendous amount of information to our understanding of the genetic control of several diseaserelated traits in humans, the same approach remains a challenge when a limited number of mouse strains are used. Nevertheless, our strain survey results and GWA studies provide a starting point for the future identification and functional characterization of genes controlling various aspects of iNKT cell development.
In conclusion, we showed a large variation in iNKT cell frequency across multiple inbred mouse strains similar to the case in humans. Relatively poor correlation in the frequency of total iNKT cells between PB and the spleen or thymus further emphasizes the importance of comprehensive analysis of lymphoid organs in humans when possible. Finally, our results will facilitate the selection of mouse strains for future studies mapping genes regulating iNKT cell development.
